Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Uhlik

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|June 12, 2016
Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agentsBeverly L Falcon, Sudhakar Chintharlapalli, Mark T Uhlik, et al.
Oncogene|November 24, 2004
MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stabilityBruce D Cuevas, Mark T Uhlik, Timothy P Garrington, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|January 28, 2005
Wiring diagrams of MAPK regulation by MEKK1, 2, and 3Mark T Uhlik, Amy N Abell, Bruce D Cuevas, et al.
Molecular and Cellular Biology|March 2, 2006
PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activationKazuhiro Nakamura, Mark T Uhlik, Nancy L Johnson, et al.
Journal of Molecular Biology|November 30, 2004
Structural and evolutionary division of phosphotyrosine binding (PTB) domainsMark T Uhlik, Brenda Temple, Sompop Bencharit, et al.
Human Molecular Genetics|July 23, 2005
CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesisJon S Zawistowski, Lisa Stalheim, Mark T Uhlik, et al.
Drug Discovery Today|September 5, 2012
High-content multiplexed tissue imaging and quantification for cancer drug discoveryBeverly L Falcon, Julie Stewart, Scharri Ezell, et al.
Anticancer Research|June 9, 2016
Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal CarcinomaAejaz Nasir, Leslie O'Neill Reising, Drew M Nedderman, et al.
Nature Cell Biology|November 25, 2003
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shockMark T Uhlik, Amy N Abell, Nancy L Johnson, et al.
Plos One|March 9, 2016
Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic MalignanciesSheng-Bin Peng, Xiaoyi Zhang, Donald Paul, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|June 12, 2016
Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agentsBeverly L Falcon, Sudhakar Chintharlapalli, Mark T Uhlik, et al.
Oncogene|November 24, 2004
MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stabilityBruce D Cuevas, Mark T Uhlik, Timothy P Garrington, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|January 28, 2005
Wiring diagrams of MAPK regulation by MEKK1, 2, and 3Mark T Uhlik, Amy N Abell, Bruce D Cuevas, et al.
Molecular and Cellular Biology|March 2, 2006
PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activationKazuhiro Nakamura, Mark T Uhlik, Nancy L Johnson, et al.
Journal of Molecular Biology|November 30, 2004
Structural and evolutionary division of phosphotyrosine binding (PTB) domainsMark T Uhlik, Brenda Temple, Sompop Bencharit, et al.
Human Molecular Genetics|July 23, 2005
CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesisJon S Zawistowski, Lisa Stalheim, Mark T Uhlik, et al.
Drug Discovery Today|September 5, 2012
High-content multiplexed tissue imaging and quantification for cancer drug discoveryBeverly L Falcon, Julie Stewart, Scharri Ezell, et al.
Anticancer Research|June 9, 2016
Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal CarcinomaAejaz Nasir, Leslie O'Neill Reising, Drew M Nedderman, et al.
Nature Cell Biology|November 25, 2003
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shockMark T Uhlik, Amy N Abell, Nancy L Johnson, et al.
Plos One|March 9, 2016
Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic MalignanciesSheng-Bin Peng, Xiaoyi Zhang, Donald Paul, et al.
Pageof 2